مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,503
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DIABETIC MACULOPATHY: DIAGNOSIS AND TREATMENT (REVIEW ARTICLES)

Pages

  69-95

Abstract

 Although microvascular dysfunction is a major component in diabetic retinopathy, recent observations have proved that alteration of macroglial, neuronal, and microglial cells in diabetes mellitus may have a major impact on breakdown of blood-retinal barrier that can lead to loss of vision. In addition, the effect of systemic pathophysiologic influences including metabolic control, blood pressure, and fluid volume in the formation of diabetic macular edema are well known. Furthermore, the role of inflammatory mechanisms in the retina in diabetes has been proposed. Scatter and focal photocoagulation have been shown to be effective in reducing visual loss but may not always prevent it. Medical TREATMENT has led to another  revolution in the TREATMENT of diabetic retinopathy. In very near future, there will be significant advances in the pharmacologic TREATMENT of diabetic retinopathy. TREATMENT with antioxidants, agents inhibiting  hyperglycemia-induced protein kinase activity and other agents will likely prevent the development and progression of diabetic retinopathy and macular edema. Availability of safe long-acting intravitreal steroids like fluocinolone acetonide and also use of vitrectomy for eyes with a tight posterior hyaloid face may further help reducing diabetic macular edema and preserve vision in patients with diabetic retinopathy.    

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SOHEYLIAN, MASOUD, & REZAIEE, A.. (2003). DIABETIC MACULOPATHY: DIAGNOSIS AND TREATMENT (REVIEW ARTICLES). BINA, 9(1 (33)), 69-95. SID. https://sid.ir/paper/42280/en

    Vancouver: Copy

    SOHEYLIAN MASOUD, REZAIEE A.. DIABETIC MACULOPATHY: DIAGNOSIS AND TREATMENT (REVIEW ARTICLES). BINA[Internet]. 2003;9(1 (33)):69-95. Available from: https://sid.ir/paper/42280/en

    IEEE: Copy

    MASOUD SOHEYLIAN, and A. REZAIEE, “DIABETIC MACULOPATHY: DIAGNOSIS AND TREATMENT (REVIEW ARTICLES),” BINA, vol. 9, no. 1 (33), pp. 69–95, 2003, [Online]. Available: https://sid.ir/paper/42280/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button